CMV

Infectious Disease

9 drugs in development·7 companies·1 clinical trial

Drug Pipeline by Phase

Approved(2)

Drug	Company
Prevymis	Merck & Co., Inc. (MRK)
t-spot.cmv	OXFORD IMMUNOTEC GLOBAL PLC (OXFD)

Phase 2(2)

Drug	Company
triplex	Fortress Biotech Inc. (FBIO)
triplex	Fortress Biotech Inc. (FBIO)

Preclinical(2)

Drug	Company
ABI-7423 (7423)	ASSEMBLY BIOSCIENCES, INC. (ASMB)
Non-nucleoside polymerase inhibitor (NNPI program)	ASSEMBLY BIOSCIENCES, INC. (ASMB)

Unknown(2)

Drug	Company
livtencity	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
livtencity	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)

Phase 1/Phase 2(1)

Drug	Company
vbi-1501	VBI VACCINES INC/BC (VBIV)

BioSniper tracks 9 drugs in development for CMV across 7 companies.

There are 1 clinical trial targeting CMV tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.